Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis
Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods A total...
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 131; no. 2; pp. 379 - 386 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Mosby, Inc
01.02.2013
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Results Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly ( P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. Conclusion The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care. |
---|---|
AbstractList | Background: The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective: We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods: A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Results: Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (PANB<ANB.001) across patient groups, differing in TNSS (FANB=ANB72.7), Physician's Global Assessment score (FANB=ANB28.6), and disease severity (FANB=ANB34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. Conclusions: The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care. The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care. BACKGROUNDThe Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control.OBJECTIVEWe sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID).METHODSA total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients.RESULTSInternal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant.CONCLUSIONThe RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care. Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Results Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly ( P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. Conclusion The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care. The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care. Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Results Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. Conclusion The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care. |
Author | Schatz, Michael, MD Garris, Cindy, MS Meltzer, Eli O., MD Stanford, Richard H., PharmD, MS Kosinski, Mark, MS Nathan, Robert, MD |
Author_xml | – sequence: 1 fullname: Meltzer, Eli O., MD – sequence: 2 fullname: Schatz, Michael, MD – sequence: 3 fullname: Nathan, Robert, MD – sequence: 4 fullname: Garris, Cindy, MS – sequence: 5 fullname: Stanford, Richard H., PharmD, MS – sequence: 6 fullname: Kosinski, Mark, MS |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27105701$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23219170$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUl2LEzEUDbLidqt_wAcJiOCDU28yH8nAIizFL1gQ1vU5ZDJ3aLrTTM2dVvrvzWyrC_ugT0luzjk5N-desLMwBGTspYCFAFG9Xy_W1vmFBCFTYQFSPmEzAbXKKi3LMzYDqEVWqaI-ZxdEa0jnXNfP2LnMpaiFghm7u8He28b3fjy843vb-_Z-Z0PLI9J2COT3GJCIDx0fV8hvVj740RNfDmGMQ8-viNL1BsPIb5FG7gPf2tGnM_FfflzxeGI8Z0872xO-OK1z9uPTx9vll-z62-evy6vrzJUgx8w5LWoo8lIXpaiKRteiAy2d7rCoWgVKdVq3ZedK1zZSFw3YopUqB4td0zmZz9nbo-42Dj93yZLZeHLY9zbgsCMjcplrkYPW_4cmfamrAkSCvn4EXQ-7GFIjJrksVAlVMj1n8ohycSCK2Jlt9BsbD0aAmVIzazOlZqbUplpKLZFenaR3zQbbv5Q_MSXAmxPAkrN9F21wnh5wSkCp7j1eHnGYvnfvMRpyKQiHrY_oRtMO_t8-Pjyiuz5Fl168wwPSQ7-GpAHzfZqvabxEEqnqNFy_AQcwy30 |
CODEN | JACIBY |
CitedBy_id | crossref_primary_10_1002_ppul_26569 crossref_primary_10_1002_alr_23090 crossref_primary_10_1016_j_intimp_2023_110623 crossref_primary_10_1016_j_aller_2019_06_007 crossref_primary_10_1016_j_bjorl_2017_10_006 crossref_primary_10_1371_journal_pone_0279748 crossref_primary_10_3389_fphar_2022_869162 crossref_primary_10_1002_iid3_418 crossref_primary_10_2500_ajra_2013_27_3928 crossref_primary_10_3389_falgy_2022_980515 crossref_primary_10_3389_fped_2021_709139 crossref_primary_10_1007_s40521_013_0007_4 crossref_primary_10_1016_j_reval_2014_10_005 crossref_primary_10_1002_alr_21992 crossref_primary_10_1002_lio2_208 crossref_primary_10_1016_j_sapharm_2020_05_012 crossref_primary_10_1002_clt2_12077 crossref_primary_10_1016_j_bjorl_2015_12_011 crossref_primary_10_1159_000524498 crossref_primary_10_1177_1721727X1301100203 crossref_primary_10_1016_j_waojou_2019_100027 crossref_primary_10_1002_lary_31347 crossref_primary_10_1002_clt2_12191 crossref_primary_10_1038_s41533_022_00315_6 crossref_primary_10_1097_ACI_0000000000000020 crossref_primary_10_1111_jvim_14629 crossref_primary_10_4168_aard_2017_5_4_175 crossref_primary_10_1002_lary_28879 crossref_primary_10_1007_s12070_020_01907_9 crossref_primary_10_1111_jdv_19862 crossref_primary_10_1111_all_13362 crossref_primary_10_1111_pai_13454 crossref_primary_10_1002_alr_22073 crossref_primary_10_1016_j_jaip_2020_02_023 crossref_primary_10_3389_fphar_2021_798263 crossref_primary_10_1002_alr_22390 crossref_primary_10_1016_j_anai_2017_08_006 crossref_primary_10_3390_jcm9072226 crossref_primary_10_1002_clt2_12062 crossref_primary_10_1016_j_sapharm_2022_03_017 crossref_primary_10_4168_aard_2017_5_4_205 crossref_primary_10_1111_all_12518 crossref_primary_10_1016_j_jaci_2020_07_007 crossref_primary_10_1155_2022_4666332 crossref_primary_10_1080_02770903_2018_1534969 crossref_primary_10_1155_2016_9471215 crossref_primary_10_1016_j_japh_2022_02_009 crossref_primary_10_1186_s13063_020_04614_6 crossref_primary_10_1111_all_15199 crossref_primary_10_2500_ajra_2016_30_4260 crossref_primary_10_2500_ajra_2015_29_4215 crossref_primary_10_1177_1945892419884789 crossref_primary_10_3389_fnut_2023_1291100 crossref_primary_10_1016_j_joim_2022_08_004 crossref_primary_10_1016_j_anai_2019_03_017 crossref_primary_10_1016_j_rmed_2020_106066 crossref_primary_10_1016_j_anai_2022_08_014 crossref_primary_10_3390_jcm8112019 crossref_primary_10_58931_cpct_2023_1S0511 crossref_primary_10_1016_j_jaip_2014_01_005 crossref_primary_10_2174_1871530319666190306100611 crossref_primary_10_1186_s12948_018_0082_y crossref_primary_10_2500_ajra_2016_30_4391 crossref_primary_10_1016_j_jaip_2014_01_001 crossref_primary_10_1016_j_anai_2017_02_007 crossref_primary_10_1111_coa_12841 crossref_primary_10_1111_all_15207 crossref_primary_10_1016_j_jaip_2024_04_030 crossref_primary_10_1016_j_jaip_2024_04_031 crossref_primary_10_3389_fped_2023_1244146 crossref_primary_10_1016_j_jaip_2021_09_035 crossref_primary_10_4193_Rhin21_282 crossref_primary_10_1007_s11655_020_3099_2 crossref_primary_10_2500_aap_2021_42_210052 crossref_primary_10_1016_j_iac_2015_12_006 crossref_primary_10_1016_j_iac_2015_12_002 crossref_primary_10_1016_j_jaip_2019_01_015 crossref_primary_10_1097_MPG_0000000000002583 crossref_primary_10_1002_alr_22659 crossref_primary_10_1177_0009922814533590 crossref_primary_10_2217_imt_2021_0353 |
Cites_doi | 10.1034/j.1399-3003.1999.14d29.x 10.1016/j.jaci.2003.09.008 10.1016/S0091-6749(97)80040-1 10.1067/mai.2001.115566 10.1016/j.jaci.2006.01.011 10.1023/A:1014485627744 10.1016/j.anai.2009.11.063 10.2500/aap.2009.30.3230 10.1016/S1081-1206(10)60488-7 10.1016/S0895-4356(99)00071-2 10.1185/03007990802711602 10.2500/aap.2007.28.2934 10.1097/01.MLR.0000062554.74615.4C 10.1016/S0091-6749(97)80041-3 10.2165/11318410-000000000-00000 10.4065/77.4.371 |
ContentType | Journal Article |
Copyright | American Academy of Allergy, Asthma & Immunology 2012 American Academy of Allergy, Asthma & Immunology 2014 INIST-CNRS Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. Copyright Elsevier Limited Feb 2013 |
Copyright_xml | – notice: American Academy of Allergy, Asthma & Immunology – notice: 2012 American Academy of Allergy, Asthma & Immunology – notice: 2014 INIST-CNRS – notice: Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. – notice: Copyright Elsevier Limited Feb 2013 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7SS 7T5 H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.jaci.2012.10.022 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE Entomology Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6825 |
EndPage | 386 |
ExternalDocumentID | 3555923221 10_1016_j_jaci_2012_10_022 23219170 27105701 S0091674912016909 1_s2_0_S0091674912016909 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: GlaxoSmithKline |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 3V. 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 7RV 7X7 8C1 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFO ACGFS ACPRK ACRLP ADBBV ADEZE ADFRT ADMUD ADVLN AEBSH AEKER AENEX AFFNX AFJKZ AFKRA AFKWA AFRAH AFRHN AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BBNVY BENPR BHPHI BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HCIFZ HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M2O M41 M7P MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~KM ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 08R AALMO ABFLS ABPIF ADALY ADGIM BBAFP BKEYQ IPNFZ IQODW PQEST PQUKI CGR CUY CVF ECM EIF NPM AAYXX CITATION 7SS 7T5 H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c502t-cc8190435845164b891f082c8fe46d7077f88d5fc5cdb284b0a4d2730aefbfc23 |
IEDL.DBID | AIKHN |
ISSN | 0091-6749 |
IngestDate | Sat Aug 17 01:19:54 EDT 2024 Thu Jul 25 11:15:39 EDT 2024 Thu Oct 10 18:10:19 EDT 2024 Thu Sep 26 15:36:17 EDT 2024 Sat Sep 28 07:51:12 EDT 2024 Thu Nov 24 18:30:57 EST 2022 Fri Feb 23 02:26:43 EST 2024 Tue Oct 15 22:55:42 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | PAR Rhinitis Control Assessment Test RCAT Seasonal allergic rhinitis Perennial allergic rhinitis SAR ROC MID PRO nonallergic rhinitis Receiver operating characteristic Allergic rhinitis patient-reported outcome rhinitis control Minimal important difference TNSS Total Nasal Symptom Score NAR Human Allergy Immunopathology Nose disease Prognosis Rhinitis Validity Immunology ENT disease Evolution Reliability |
Language | English |
License | CC BY 4.0 Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c502t-cc8190435845164b891f082c8fe46d7077f88d5fc5cdb284b0a4d2730aefbfc23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 23219170 |
PQID | 1644750604 |
PQPubID | 105664 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1323813088 proquest_miscellaneous_1284286401 proquest_journals_1644750604 crossref_primary_10_1016_j_jaci_2012_10_022 pubmed_primary_23219170 pascalfrancis_primary_27105701 elsevier_sciencedirect_doi_10_1016_j_jaci_2012_10_022 elsevier_clinicalkeyesjournals_1_s2_0_S0091674912016909 |
PublicationCentury | 2000 |
PublicationDate | 2013-02-01 |
PublicationDateYYYYMMDD | 2013-02-01 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: St. Louis |
PublicationTitle | Journal of allergy and clinical immunology |
PublicationTitleAlternate | J Allergy Clin Immunol |
PublicationYear | 2013 |
Publisher | Mosby, Inc Elsevier Elsevier Limited |
Publisher_xml | – name: Mosby, Inc – name: Elsevier – name: Elsevier Limited |
References | Nathan, Sorkness, Kosinski, Schatz, Li, Marcus (bib7) 2004; 113 Nunnally, Bernstein (bib13) 1994 Nathan, Meltzer, Selner, Storms (bib1) 1997; 99 Nathan (bib2) 2007; 28 Wyrwich, Tierney, Wolinsky (bib17) 1999; 52 Juniper, O'Byrne, Guyatt (bib9) 1999; 14 Nathan, Dalal, Stanford, Meltzer, Schatz, Derebery (bib11) 2010; 3 Kerlinger (bib15) 1973 (bib21) 2008 Schatz, Zeiger, Chen, Yang, Corrao, Quinn (bib6) 2008; 101 Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda: US Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute, National Asthma Education and Prevention Program; 2007. NIH publication no. 07-40511-440. Available at Cohen (bib14) 1988 Wyrwich, Tierney, Wolinsky (bib18) 2002; 11 Meltzer, Nathan, Derebery, Stang, Campbell, Yeh (bib3) 2009; 30 Accessed October 1, 2012. Schatz, Meltzer, Nathan, Derebery, Mintz, Stanford (bib12) 2010; 104 Kosinski, Kite, Yang, Carranza-Rozenzwieg, Williams (bib20) 2009; 25 Norman, Sloan, Wyrwich (bib16) 2003; 41 Guyatt, Osborn, Wu, Wywrich, George (bib19) 2002; 77 Meltzer, Nathan, Selner, Storms (bib5) 1997; 99 Schatz, Sorkness, Li, Marcus, Murray, Nathan (bib8) 2006; 117 Meltzer (bib4) 2001; 108 Guyatt (10.1016/j.jaci.2012.10.022_bib19) 2002; 77 Nathan (10.1016/j.jaci.2012.10.022_bib2) 2007; 28 Wyrwich (10.1016/j.jaci.2012.10.022_bib18) 2002; 11 Schatz (10.1016/j.jaci.2012.10.022_bib12) 2010; 104 Nathan (10.1016/j.jaci.2012.10.022_bib7) 2004; 113 Wyrwich (10.1016/j.jaci.2012.10.022_bib17) 1999; 52 Nathan (10.1016/j.jaci.2012.10.022_bib1) 1997; 99 Kosinski (10.1016/j.jaci.2012.10.022_bib20) 2009; 25 Nathan (10.1016/j.jaci.2012.10.022_bib11) 2010; 3 Meltzer (10.1016/j.jaci.2012.10.022_bib3) 2009; 30 Cohen (10.1016/j.jaci.2012.10.022_bib14) 1988 Meltzer (10.1016/j.jaci.2012.10.022_bib4) 2001; 108 Juniper (10.1016/j.jaci.2012.10.022_bib9) 1999; 14 Kerlinger (10.1016/j.jaci.2012.10.022_bib15) 1973 Meltzer (10.1016/j.jaci.2012.10.022_bib5) 1997; 99 Schatz (10.1016/j.jaci.2012.10.022_bib6) 2008; 101 Nunnally (10.1016/j.jaci.2012.10.022_bib13) 1994 (10.1016/j.jaci.2012.10.022_bib21) 2008 10.1016/j.jaci.2012.10.022_bib10 Schatz (10.1016/j.jaci.2012.10.022_bib8) 2006; 117 Norman (10.1016/j.jaci.2012.10.022_bib16) 2003; 41 |
References_xml | – volume: 104 start-page: 118 year: 2010 end-page: 124 ident: bib12 article-title: Psychometric validation of the Rhinitis Control Assessment Test (RCAT): a brief, self administered instrument for evaluating rhinitis symptom control publication-title: Ann Allergy Asthma Immunol contributor: fullname: Stanford – volume: 101 start-page: 240 year: 2008 end-page: 247 ident: bib6 article-title: The burden of rhinitis in a managed care organization publication-title: Ann Allergy Asthma Immunol contributor: fullname: Quinn – year: 1994 ident: bib13 article-title: Psychometric theory contributor: fullname: Bernstein – volume: 99 start-page: S808 year: 1997 end-page: S814 ident: bib1 article-title: Prevalence of allergic rhinitis in the United States publication-title: J Allergy Clin Immunol contributor: fullname: Storms – volume: 99 start-page: S815 year: 1997 end-page: S819 ident: bib5 article-title: Quality of life and rhinitis symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires publication-title: J Allergy Clin Immunol contributor: fullname: Storms – volume: 117 start-page: 549 year: 2006 end-page: 556 ident: bib8 article-title: The Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists publication-title: J Allergy Clin Immunol contributor: fullname: Nathan – volume: 25 start-page: 717 year: 2009 end-page: 727 ident: bib20 article-title: Comparability of Asthma Control Test telephone interview administration format with self-administered mail-out mail-back format publication-title: Curr Med Res Opin contributor: fullname: Williams – volume: 52 start-page: 861 year: 1999 end-page: 873 ident: bib17 article-title: Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life publication-title: J Clin Epidemiol contributor: fullname: Wolinsky – volume: 11 start-page: 1 year: 2002 end-page: 7 ident: bib18 article-title: Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire publication-title: Qual Life Res contributor: fullname: Wolinsky – year: 1973 ident: bib15 article-title: Foundations of behavioral research contributor: fullname: Kerlinger – volume: 3 start-page: 91 year: 2010 end-page: 99 ident: bib11 article-title: Qualitative development of the Rhinitis Control Assessment Test (RCAT), an instrument for evaluating rhinitis symptom control publication-title: The Patient: Patient Centered Outcomes Research contributor: fullname: Derebery – volume: 108 start-page: S45 year: 2001 end-page: S53 ident: bib4 article-title: Quality of life in adults and children with allergic rhinitis publication-title: J Allergy Clin Immunol contributor: fullname: Meltzer – volume: 77 start-page: 317 year: 2002 end-page: 383 ident: bib19 article-title: Methods to explain the clinical significance of health status measures publication-title: Mayo Clin Proc contributor: fullname: George – volume: 28 start-page: 3 year: 2007 end-page: 9 ident: bib2 article-title: The burden of allergic rhinitis publication-title: Allergy Asthma Proc contributor: fullname: Nathan – volume: 14 start-page: 902 year: 1999 end-page: 907 ident: bib9 article-title: Development and validation of a questionnaire to measure asthma control publication-title: Eur Respir J contributor: fullname: Guyatt – volume: 30 start-page: 244 year: 2009 end-page: 254 ident: bib3 article-title: Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey publication-title: Allergy Asthma Proc contributor: fullname: Yeh – year: 1988 ident: bib14 article-title: Statistical power analysis for the Behavioral Sciences contributor: fullname: Cohen – volume: 41 start-page: 582 year: 2003 end-page: 592 ident: bib16 article-title: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation publication-title: Med Care contributor: fullname: Wyrwich – volume: 113 start-page: 59 year: 2004 end-page: 65 ident: bib7 article-title: Development of the Asthma Control Test (ACT): a survey for assessing asthma control publication-title: J Allergy Clin Immunol contributor: fullname: Marcus – year: 2008 ident: bib21 article-title: FDA guidance for industry, patient reported outcome measures: use in medical product development to support labeling claims – volume: 14 start-page: 902 year: 1999 ident: 10.1016/j.jaci.2012.10.022_bib9 article-title: Development and validation of a questionnaire to measure asthma control publication-title: Eur Respir J doi: 10.1034/j.1399-3003.1999.14d29.x contributor: fullname: Juniper – volume: 113 start-page: 59 year: 2004 ident: 10.1016/j.jaci.2012.10.022_bib7 article-title: Development of the Asthma Control Test (ACT): a survey for assessing asthma control publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2003.09.008 contributor: fullname: Nathan – ident: 10.1016/j.jaci.2012.10.022_bib10 – volume: 99 start-page: S808 issue: suppl year: 1997 ident: 10.1016/j.jaci.2012.10.022_bib1 article-title: Prevalence of allergic rhinitis in the United States publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(97)80040-1 contributor: fullname: Nathan – volume: 108 start-page: S45 issue: suppl year: 2001 ident: 10.1016/j.jaci.2012.10.022_bib4 article-title: Quality of life in adults and children with allergic rhinitis publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2001.115566 contributor: fullname: Meltzer – volume: 117 start-page: 549 year: 2006 ident: 10.1016/j.jaci.2012.10.022_bib8 article-title: The Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2006.01.011 contributor: fullname: Schatz – volume: 11 start-page: 1 year: 2002 ident: 10.1016/j.jaci.2012.10.022_bib18 article-title: Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire publication-title: Qual Life Res doi: 10.1023/A:1014485627744 contributor: fullname: Wyrwich – volume: 104 start-page: 118 year: 2010 ident: 10.1016/j.jaci.2012.10.022_bib12 article-title: Psychometric validation of the Rhinitis Control Assessment Test (RCAT): a brief, self administered instrument for evaluating rhinitis symptom control publication-title: Ann Allergy Asthma Immunol doi: 10.1016/j.anai.2009.11.063 contributor: fullname: Schatz – volume: 30 start-page: 244 year: 2009 ident: 10.1016/j.jaci.2012.10.022_bib3 article-title: Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey publication-title: Allergy Asthma Proc doi: 10.2500/aap.2009.30.3230 contributor: fullname: Meltzer – volume: 101 start-page: 240 year: 2008 ident: 10.1016/j.jaci.2012.10.022_bib6 article-title: The burden of rhinitis in a managed care organization publication-title: Ann Allergy Asthma Immunol doi: 10.1016/S1081-1206(10)60488-7 contributor: fullname: Schatz – volume: 52 start-page: 861 year: 1999 ident: 10.1016/j.jaci.2012.10.022_bib17 article-title: Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(99)00071-2 contributor: fullname: Wyrwich – volume: 25 start-page: 717 year: 2009 ident: 10.1016/j.jaci.2012.10.022_bib20 article-title: Comparability of Asthma Control Test telephone interview administration format with self-administered mail-out mail-back format publication-title: Curr Med Res Opin doi: 10.1185/03007990802711602 contributor: fullname: Kosinski – volume: 28 start-page: 3 year: 2007 ident: 10.1016/j.jaci.2012.10.022_bib2 article-title: The burden of allergic rhinitis publication-title: Allergy Asthma Proc doi: 10.2500/aap.2007.28.2934 contributor: fullname: Nathan – year: 1994 ident: 10.1016/j.jaci.2012.10.022_bib13 contributor: fullname: Nunnally – year: 1988 ident: 10.1016/j.jaci.2012.10.022_bib14 contributor: fullname: Cohen – volume: 41 start-page: 582 year: 2003 ident: 10.1016/j.jaci.2012.10.022_bib16 article-title: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation publication-title: Med Care doi: 10.1097/01.MLR.0000062554.74615.4C contributor: fullname: Norman – year: 2008 ident: 10.1016/j.jaci.2012.10.022_bib21 – volume: 99 start-page: S815 issue: suppl year: 1997 ident: 10.1016/j.jaci.2012.10.022_bib5 article-title: Quality of life and rhinitis symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(97)80041-3 contributor: fullname: Meltzer – volume: 3 start-page: 91 year: 2010 ident: 10.1016/j.jaci.2012.10.022_bib11 article-title: Qualitative development of the Rhinitis Control Assessment Test (RCAT), an instrument for evaluating rhinitis symptom control publication-title: The Patient: Patient Centered Outcomes Research doi: 10.2165/11318410-000000000-00000 contributor: fullname: Nathan – year: 1973 ident: 10.1016/j.jaci.2012.10.022_bib15 contributor: fullname: Kerlinger – volume: 77 start-page: 317 year: 2002 ident: 10.1016/j.jaci.2012.10.022_bib19 article-title: Methods to explain the clinical significance of health status measures publication-title: Mayo Clin Proc doi: 10.4065/77.4.371 contributor: fullname: Guyatt |
SSID | ssj0009389 |
Score | 2.4450727 |
Snippet | Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the... The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. We sought to test the reliability,... BACKGROUNDThe Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control.OBJECTIVEWe sought to test the... Background: The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective: We sought to test... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 379 |
SubjectTerms | Adolescent Adult Aged Allergic rhinitis Allergies Allergy and Immunology Asthma Biological and medical sciences Diagnostic Self Evaluation Disease control Evaluation Studies as Topic Female Fundamental and applied biological sciences. Psychology Fundamental immunology Geriatrics Humans Immunopathology Longitudinal Studies Male Medical sciences Middle Aged Non tumoral diseases nonallergic rhinitis Nose Otorhinolaryngology. Stomatology patient-reported outcome Patients Ratings & rankings Reproducibility of Results Review boards Rhinitis Rhinitis - diagnosis Rhinitis - physiopathology rhinitis control Rhinitis Control Assessment Test Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Severity of Illness Index Surveys and Questionnaires Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology Validity Young Adult |
Title | Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0091674912016909 https://dx.doi.org/10.1016/j.jaci.2012.10.022 https://www.ncbi.nlm.nih.gov/pubmed/23219170 https://www.proquest.com/docview/1644750604 https://search.proquest.com/docview/1284286401 https://search.proquest.com/docview/1323813088 |
Volume | 131 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEB_OHogg4rfRs6zgm-Yu2WySzWMpHlXxHuQO7m3JfmFOSEvTe_DFv92Z7qblkPrgW0mzyXRmdubX5DczAO9dYaVHR0htW9PTqtylmIQr3O61FlzYtrVblu9FtbgSX67L6yOYj7UwRKuMsT_E9G20jkfOojbPVl1HNb4NUeibnFNHESriO8Z0JMQEjmefvy4u9r13CxlQcJOntCDWzgSa101rOmJ48VMieXF-KD89XLUDas2HcReH8eg2L50_hkcRULJZkPkJHLn-Kdz_Fl-ZP4OfRDoOzbh_fWToV53dfmp7y9aRIBsCHlt6hnCQff_REaNoYPNAY2ezXfdOdomisK5nsR3rwOg5LlvHFc_h6vzT5XyRxgkLqSkzvkmNIUCAiEnSvF6hZZN7xARGeicqW2d17aW0pTelsRoTmc5aYRHwZK3z2htevIBJv-zdK2BNpjPPi1KXshGVKxurHdrG1Do3srAugQ-jXtUqNNJQI8PsRpEVFFmBjqEVEqhH1auxRBSDmhviDhtUrgauMvWXFyRQ7lbecSSFOeKfd5zesfBOSF7TKOQsT-BkNLnaS1FRw0RqQJTAu93XuEPptUvbu-UtnoOK47ISdImD5xQEnQoM-Qm8DO60F6Dg9Kc6e_2fv-wNPODbGR7EwTmByWZ9694iktroKdw7_Z1P4375A0vsHBg |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB5CAm2hhL6rNkm30FurRFq9VsdgEtw2yaE4kNuifRGlIBvLOfTS394Z7comFPfQm5FX0nhmduaz9M0MwCebGeHQEWLTVPS0KrUxJuESt3ulcp6bpjEDy_eqnF7n326Kmx2YjLUwRKsMsd_H9CFahyMnQZsni7alGt-aKPR1yqmjCBXx7REaIF7X8e8Nz6POhMfAdRrT8lA540led41uid_Fj4nixfm27PR00fSoM-eHXWxHo0NWOn8G-wFOslMv8XPYsd0LeHQZXpi_hJ9EOfatuH99YehVrRk-NZ1hy0CP9eGOzR1DMMh-3LbEJ-rZxJPY2em6dyeboSis7VhoxtozeorLluGMV3B9fjabTOMwXyHWRcJXsdYEBxAvCZrWmytRpw4RgRbO5qWpkqpyQpjC6UIbhWlMJU1uEO4kjXXKaZ69ht1u3tm3wOpEJY5nhSpEnZe2qI2yaBldqVSLzNgIPo96lQvfRkOO_LI7SVaQZAU6hlaIoBpVL8cCUQxptg_7q5ep7LlM5F8-EEGxPvOBG0nMEP-849EDC6-F5BUNQk7SCA5Gk8uNFCW1S6T2QxF8XH-N-5NeujSdnd_jGlQcF2VOl9i6JiPglGHAj-CNd6eNABmnv9TJu__8ZR_g8XR2eSEvvl59fw9P-DDNg9g4B7C7Wt7bQ8RUK3U07Jk_1wgc7Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reliability%2C+validity%2C+and+responsiveness+of+the+Rhinitis+Control+Assessment+Test+in+patients+with+rhinitis&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Meltzer%2C+Eli+O.&rft.au=Schatz%2C+Michael&rft.au=Nathan%2C+Robert&rft.au=Garris%2C+Cindy&rft.date=2013-02-01&rft.issn=0091-6749&rft.volume=131&rft.issue=2&rft.spage=379&rft.epage=386&rft_id=info:doi/10.1016%2Fj.jaci.2012.10.022&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jaci_2012_10_022 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674913X00028%2Fcov150h.gif |